Its a promising option for people looking to lose weight, especially when paired with guidance from a provider who understands how it works and how to support your body during treatment
It activates the GLP-1 receptors in the gastrointestinal tract, pancreas, and brain to lower blood sugar levels in patients with type 2 diabetes and promote weight loss in obese and overweight individuals
One 2024 study at the Smell and Taste Center at the University of Pennsylvania (source) found evidence of GLP1 agonists significantly depressing the perception of all five basic taste qualities. Interestingly, while all participants in the study experienced a slight decline in their sense of smell, it was not considered statistically significant suggesting that olfactory changes may be more individualised, or more complex to detect in standardised tests
The starting dose is now available at more than 70,000 US pharmacies such as CVS and Costco, as well as some telehealth providers including Ro, LifeMD and Weight Watchers
September 2024 Early discovery and motion practice have been scheduled on two issues: preemption (whether federal law overrides the case) and whether warning labels were clear enough